Comparison of Demitron and promethazin in treatment of nausea and vomiting in pregnancy
Not Applicable
- Conditions
- nausea and vomiting in pregnancy.Hyperemesis gravidarum with metabolic disturbance
- Registration Number
- IRCT201201298862N1
- Lead Sponsor
- Kerman University of Medical Sciences (vice chancellor for research)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
inclusion criteria: pregnant women with gestation of 20 weeks or less; dehydration due to nausia and vomiting
exclusion criteria: multiple pregnancy; nonviable pregnancy; concomitant emetogenic pathology associated with the symptomatology (hepatitis, gastrointestinal disorder,... )
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea and vomiting. Timepoint: 48 hours after drug beginning. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Drug adverse reactions. Timepoint: 48 hours after drug beginning. Method of measurement: questionnaire.